Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Practice|March 5, 2014
The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditionsG Adler, B Mueller, K Articus
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 14, 2001
Scale-sensitive fractal analysis using the patchwork method for the assessment of skin roughnessK Articus, C A Brown, K P Wilhelm
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 13, 2002
Development and validation of a semiautomatic image analysis system for measuring skin desquamation with D-SquamesK-P Wilhelm, K Kaspar, F Schumann, et al.
International Journal of Clinical Practice|June 8, 2011
A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's diseaseK Articus, M Baier, F Tracik, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 17, 2011
Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone massP Hadji, V Ziller, D Gamerdinger, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2011
Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone massP Hadji, D Gamerdinger, W Spieler, et al.
Pageof 1